English
Specials
My Feed
Moneycontrol PRO
you are here:

Gilead Sciences

SYMBOL:GILD|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
6
6
0
0
.
5
5
1
1
1
1
2.29 (2.03%)

As on 06 Sep, 2025 | 01:29 IST

Day Range
112.41
115.80
LH
52 Week Range
78.27
121.61
LH
Advance Chart
Open112.60
Previous Close112.77
Beta0.25
High115.80
Low112.41
TTM EPS See historical trend   7.74(+64.68% YoY)
52 Week High121.61
52 Week Low78.27
TTM PE See historical trend    14.86(Average PE)
Mkt. Cap ($ Billion)143.46
Dividend Yield2.81

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Bullish
See Details  
Historical Rating  
Moving AveragesBullish
Technical IndicatorsNeutral
Moving Averages CrossoversNeutral

Pivot levels

TypeR1R2R3PPS1S2S3
Classic113.61 114.49 115.15112.95 112.08 111.42 110.54
Fibonacci113.54 113.90 114.49112.95 112.37 112.00 111.42
Camarilla112.88 113.02 113.16112.95 112.60 112.46 112.32

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5113.26
10113.63
20116.22
50113.46
100109.77
200104.67

Returns

Price Performance
1 Week0.32%
1 Month0.72%
3 Months3.45%
YTD24.58%
1 Year44.81%
3 Years84.23%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly732.30-0.25695.17123.705.920.96746.56/0.00-13.33Neutral
J&J175.46-0.75422.3816.7310.492.88177.67/0.0012.33Neutral
AbbVie207.90-0.08366.9517.4411.924.39210.41/0.007.73Bearish
Merck83.22-1.01211.1726.933.092.5385.48/0.000.24Bearish
Amgen313.690.42163.2417.4917.423.52329.72/215.32-1.81Bearish
+ See More

Market news

Wall Street indexes end lower as jobs data fuels economic worries

September 6, 2025 10:13 AM
Show More

About the company

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company's portfolio of products and pipeline of investigational drugs includes treatments for HIV/acquired immune deficiency syndrome (AIDS), COVID-19, liver diseases, hematology/oncology/cell therapy and other. Its products for HIV/AIDS patients include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada and Atripla. It offers Veklury to patients with COVID-19. The Company's products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Viread and Vosevi. Its products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy and Zydelig. Other products include Letairis, Ranexa and AmBisome. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The Company operates in more than 335 countries worldwide.